Omega Healthcare Investors price to sales ratio OHI

Market value divided by revenue over the last twelve months, since 2011.

Today, Oct 23, 2026: 10.9×
10-year median: 8.3×
Against its 10-year history: 89th; percentile: 0 is its lowest day, 100 its highest
10-year range: 5.5× to 12.5×
Peer median: 6.8×

Omega Healthcare Investors' price to sales ratio is 10.9× as of Oct 23, 2026.

That is above its ten-year median of 8.3×, higher than on 89% of days in the last ten years.

Over that time it ranged from 5.5× in Mar 2020 to 12.5× in Jul 2026.

The median for 10 specialty REITs of a similar size is 6.8×.

Price to sales ratio over time

median 8.3×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	10.9×	10.5×	12.5×
2025	11.4×	9.6×	11.8×
2024	10.1×	7.8×	11.0×
2023	8.8×	6.7×	9.8×
2022	6.7×	5.7×	7.7×
2021	6.6×	6.1×	10.0×
2020	9.4×	5.5×	10.8×
2019	10.1×	8.0×	10.9×
2018	8.0×	5.5×	8.6×
2017	5.9×	5.8×	7.6×
2016	7.0×	6.3×	9.7×
2015	9.8×	9.1×	12.8×
2014	10.4×	9.1×	11.1×
2013	9.2×	8.3×	11.7×
2012	8.0×	7.0×	8.4×
2011	7.0×	5.7×	8.3×

Against its peers

Companies in REIT - Specialty nearest Omega Healthcare Investors' size, closest first, today.

Company	Price to sales ratio
OHIOmega Healthcare Investors	10.9×
WYWeyerhaeuser	2.1×
MAAMID America Apartment Communities	6.3×
NLYAnnaly Capital Management	n/m
REGRegency Centers	8.4×
WPCW. P. Carey	8.1×
DOCHealthpeak Properties	4.5×
LAMRLamar Advertising	6.8×
KIMKimco Realty	7.2×
ELSEquity Lifestyle Properties	7.6×
HSTHost Hotels & Resorts	2.7×
Peer median	6.8×

What the price to sales ratio tells you

Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.

Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.

More on Omega Healthcare Investors

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.